No increased CV risk with systemic psoriasis therapies?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1367卷 / 1期
关键词：
Psoriasis; Infliximab; Etanercept; Adalimumab; Plaque Psoriasis;
D O I：
10.2165/00128415-201113670-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [31] Combination use of systemic therapies in psoriasis: Baseline characteristics from the Corrona Psoriasis Registry
    Bonomo, Lauren
    Abittan, Brian
    Hashim, Peter
    Karki, Chitra
    Mason, Marc
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB79 - AB79
  • [32] Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
    Chiricozzi, Andrea
    Gisondi, Paolo
    Bellinato, Francesco
    Girolomoni, Giampiero
    VACCINES, 2020, 8 (04) : 1 - 12
  • [33] Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes
    Yiu, Zenas Z. N.
    Warren, Richard B.
    Mrowietz, Ulrich
    Griffiths, Christopher E. M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (04) : 329 - 334
  • [34] The safety of alefacept used in combination with conventional systemic psoriasis therapies
    Cather, J
    Mann, J
    Abramovits, W
    Menter, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P199 - P199
  • [35] Treatment of psoriasis. Part 2. Systemic therapies
    Lebwohl, M
    Ali, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) : 649 - 661
  • [36] Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; US experiences
    Kormeili, T
    Lowe, NJ
    Yamauchi, PS
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (01) : 3 - 15
  • [37] Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored
    Lecluse, L. L. A.
    Nolthenius, J. L. E. Tutein
    Bos, J. D.
    Spuls, P. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1340 - 1343
  • [38] Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies
    Ormerod, A. D.
    Augustin, M.
    Baker, C.
    Chosidow, O.
    Cohen, A. D.
    Dam, T. N.
    Garcia-Doval, I.
    Lecluse, L. L.
    Schmitt-Egenolf, M.
    Spuls, P. I.
    Watson, K. D.
    Naldi, L.
    DERMATOLOGY, 2012, 224 (03) : 236 - 243
  • [39] An overview of extracutaneous side effects related to systemic therapies in psoriasis
    Potocnik, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 13 - 13
  • [40] Impaired langerhans' cell migration in psoriasis: effect of systemic therapies
    Dearman, R. J.
    Mellody, K. T.
    Shaw, F.
    Ogden, S.
    Kimber, I.
    Griffiths, C. E. M.
    IMMUNOLOGY, 2012, 137 : 651 - 651
12345